This article was originally published in The Jewish Observer.
One participant in the Vanderbilt study is Jewish Family Service Clinical Director, Toni Jacobsen, who recently completed her two vaccine trial. During her final visit to the clinic, Toni spent about 90 minutes and interacted with over a half dozen people. The visit began with a check-in with the Nurse Practitioner Anna Gallion, who took Toni’s vital signs, took a COVID-19 swab, and interviewed her about her recent health status. After a waiting period of about 20 minutes, Gallion left the room and another nurse entered to administer the vaccine. According to Anna Gallion, the study is what is called, “observer-blind,” meaning the process aims to minimize or eliminate bias or preferential treatment about which participant receives the vaccine and which receives a placebo.